Photo from wikipedia
I read with great interest the article by Mease et al 1 because equivalence in efficacy with lesser secukinumab total doses could be less expensive to payers and more safe and comfortable… Click to show full abstract
I read with great interest the article by Mease et al 1 because equivalence in efficacy with lesser secukinumab total doses could be less expensive to payers and more safe and comfortable to patients. However, I am somewhat disappointed with the reported results. The …
Keywords:
loading dose;
150 without;
treatment groups;
superior 150;
dose treatment;
groups superior
Journal Title: Annals of the Rheumatic Diseases
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Annals of the Rheumatic Diseases
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!